OCTN Cation Transporters in Health and Disease: Role as Drug Targets and Assay Development
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The three members of the organic cation transporter novel subfamily are known to be involved in interactions with xenobiotic compounds. These proteins are characterized by 12 transmembrane segments connected by nine short loops and two large hydrophilic loops. It has been recently pointed out that acetylcholine is a physiological substrate of OCTN1. Its transport could be involved in nonneuronal cholinergic functions. OCTN2 maintains the carnitine homeostasis, resulting from intestinal absorption, distribution to tissues, and renal excretion/reabsorption. OCTN3, identified only in mouse, mediates also carnitine transport. OCTN1 and OCTN2 are associated with several pathologies, such as inflammatory bowel disease, primary carnitine deficiency, diabetes, neurological disorders, and cancer, thus representing useful pharmacological targets. The function and interaction with drugs of OCTNs have been studied in intact cell systems and in proteoliposomes. The latter experimental model enables reduced interference from other transporters or enzyme pathways. Using proteoliposomes, the molecular bases of toxicity of some drugs have recently been revealed. Therefore, proteoliposomes represent a promising experimental tool suitable for large-scale molecular screening of interactions of OCTNs with chemicals regarding human health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 2×
“The decline in brain function is typical of neurological diseases, such as Alzheimer’s and Parkinson’s diseases.(54) In this scenario, any metabolic intervention that could improve mitochondrial function and ATP production may have great importance.”
BackgroundHost-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“These findings suggest the existence of metabolic signatures of microbial infections stimulating immunosurveillance.(44,121,122) The inflammatory diseases are comparable to autoimmune disorders.”
BackgroundMembrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228 · cited 1×
“This anti-inflammatory role was described in 2003 for innervated tissues and hypothesized for nonnervous cells.(86) The transporter is more efficient in catalyzing efflux toward the extracellular environment than uptake of acetylcholine, which is depressed by extracellular Na.”
BackgroundDrug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“In this district, carnitine reaches the highest level of the body.(43,52,53) Functional data obtained in cells, in membrane vesicles, or in proteoliposomes demonstrated that this transport system has a welldefined substrate specificity for carnitine and its derivatives, whose transport is coupled to sodium (Table 1).”
BackgroundMechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 1×
“Moreover, it has been reported for several years that lipid-induced insulin resistance is a hallmark for diabetes mellitus patients.(49,50,108) Carnitine, in fact, would facilitate the export of fatty acids from tissues as acylcarnitines, alleviating lipid-induced insulin resistance and thus stimulating glucose utiliz…”
BackgroundReciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 3×
“Dietary changes, drug treatments, and infections can alter gut microbiota composition, referred to as dysbiosis, which is a hallmark of IBD patients.(122) Very recently, the involvement of specific vitamin-based bacterial metabolites in host immune response activation has been proposed.”
BackgroundMR1 presents microbial vitamin B metabolites to MAIT cells
Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., Bhati, M., Chen, Z., Kostenko, L., Reantragoon, R., et al. (2012) · Nature · doi:10.1038/nature11605 · Cited by 1,351
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
Cited by
Carnitine transport and fatty acid oxidation
Longo, N., Frigeni, M., & Pasquali, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.023 · Cited by 996
Kou, L., Bhutia, Y. D., Yao, Q., He, Z., Sun, J., & Ganapathy, V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00027 · Cited by 308
The biology of ergothioneine, an antioxidant nutraceutical
Borodina, I., Kenny, L. C., McCarthy, C. M., Paramasivan, K., Pretorius, E., Roberts, T. J., van der Hoek, S. A., & Kell, D. B. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422419000301 · Cited by 296
“As yet, no other transporter with significant activity for ERG in humans is known, making it a potentially interesting drug target (183,184) .”
BackgroundStory behind meldonium–from pharmacology to performance enhancement: a narrative review
Schobersberger, W., Dünnwald, T., Gmeiner, G., & Blank, C. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096357 · Cited by 61
Jurkiewicz, D., Michalec, K., Skowronek, K., & Nałęcz, K. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.02.014 · Cited by 15
Metadata
- Authors
- Pochini, L., Scalise, M., Galluccio, M., & Indiveri, C.
- Venue
- SLAS Discovery
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 18
- Issue
- 8
- Pages
- 851-867
- ISSN
- 2472-5552 (ISSN-L)
- OpenAlex
- W2140750582
- Cited by
- 108
- References
- 17
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: OCTN Cation Transporters in Health and Disease: Role as Drug Targets and Assay Development. https://app.cochat.ai/papers/10.1177/1087057113493006
- The paper
- Pochini, L., Scalise, M., Galluccio, M., & Indiveri, C. (2013). OCTN Cation Transporters in Health and Disease: Role as Drug Targets and Assay Development. SLAS Discovery. https://doi.org/10.1177/1087057113493006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.